Clinical Trial Update: Nitric Oxide During Bypass for Arterial Switch Operation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating nitric oxide during bypass in arterial switch operation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Cardiac Output Syndrome
• Transposition of Great Vessels

Drugs mentioned

• Nitric Oxide (nitric oxide)

Snippet

Sponsor: Murdoch Childrens Research Institute | Conditions: Low Cardiac Output Syndrome, Transposition of Great Vessels | Phase 3 | Status: COMPLETED